Subhendu Basu
Chief Executive Officer Telum Therapeutics
Seminars
Wednesday 25th March 2026
Reviving Confidence in Lysins as a Next-Generation Solution for Resistant Infections to Unlock Novel Treatments for Patients in Need
3:30 pm
- Exploring how lysins deliver rapid, contact-based bacterial killing with no observed resistance, whilst building strategies for de-immunising capsid proteins and engineering less reactive formulations
- Learning from past clinical experiences to design smarter trials and overcome funding setbacks
- Showcasing how computational engineering and compassionate use models are unlocking a viable path forward for lysin therapeutics
